
How New Zealand’s Whakarongorau Aotearoa is improving equity in healthcare
CEO Andrew Slater describes how the telehealth company has scaled up to meet unprecedented demand while staying true to its mission.
Whether you’re a payor, provider or government entity, social determinants are a critical component of healthcare and pharmaceuticals in the twenty-first century.
In our new report, PwC lays out five steps for bold action that organisations can take to lead in a world in which social determinants assume a more prominent role. The research is backed by new results from a global survey conducted by PwC’s Health Research Institute, along with interviews with healthcare leaders and analysis of dozens of case studies.
CEO Andrew Slater describes how the telehealth company has scaled up to meet unprecedented demand while staying true to its mission.
In our new report, PwC’s look at four top themes that now affect global healthcare providers, insurers, pharmaceutical and life sciences companies, new entrants and employers.
COVID-19 has highlighted the importance of keeping patients, families, and caregivers informed and connected, and of valuing them as co-creators in building the future of healthcare delivery.
CEO Albert Bourla discusses how a company founded in the 19th century is taking on the biggest health challenges of the 21st century.
Quentin Cole
UK Government and Health Industries Leader, Partner, PwC United Kingdom
Tel: +44 (0) 7770 303 846